Minimal residual disease testing services
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C10G22D0036
- Awardee
-
Natera Inc. UEI VD6KZ6NCS9K8
- Awarding agency
-
Headquarters
Department of Veterans Affairs
- Task orders
- 4 $1,228,893 obligated
Award facts
- Opportunity
-
- Q301--Molecular Residual Disease (MRD) Testing Services Pre-Solicitation · 36C10G22R0020 · Posted May 19, 2022
- Combined order value
- $1,228,893 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 18% used
- $6,720,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs (VA) Headquarters awarded an Indefinite Delivery Contract (IDC) to Natera Inc., a global leader in cell-free DNA testing, valued at up to $6.72 million over two years. The contract is for Natera to provide minimal residual disease (MRD) testing services, which analyze cell-free DNA biomarkers in patient blood samples to detect remaining cancer cells after initial treatment. This information helps guide ongoing cancer treatment decisions for VA patients.
Under this IDC, the VA has issued three delivery orders to Natera. The first, worth $496,460, funds research and development activities related to MRD testing through Fiscal Year 2024. The second, valued at $2.8 million, provides the MRD testing services utilizing Natera's proprietary cell-free DNA platform. The third, worth $499,447, extends the period of performance for six months. All delivery orders are firm fixed price with no set-aside designation, to be performed at Natera's facility in Austin, Texas. This IDC supports the VA's National Oncology Program's goal of securing specialized reference laboratory services for molecular residual disease testing in solid tumors.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Modification to extend the POP for six (6) months | Headquarters | $140,595 | |
| New task order to extend the POP for six (6) months | Headquarters | $499,447 | |
| Task order to fund mrdt for FY24 | Headquarters | $496,460 | |
| Minimal residual disease testing services | Headquarters | $92,391 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C10G22D0036?
36C10G22D0036 was awarded to Natera Inc. by Headquarters (Department of Veterans Affairs) on September 15, 2022.
How much is contract 36C10G22D0036 worth?
Orders under 36C10G22D0036 have obligated $1,228,893. 36C10G22D0036's own ceiling is $6,720,000.
How many orders have been placed under contract 36C10G22D0036?
4 orders have been placed under 36C10G22D0036, the latest on March 15, 2025.
Who can order from contract 36C10G22D0036?
36C10G22D0036 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C10G22D0036 competed?
The extent of competition for 36C10G22D0036 was competed under sap. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV